Letter to the editor [1]

Menopause

Volumn 14, Issue 5, 2007, Pages 958-

  Messina, Mark ^a  

^a Nutrition Matters Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE;

BREAST CELL; CELL PROLIFERATION; DATA ANALYSIS; DRUG EFFECT; DRUG SAFETY; HORMONAL THERAPY; HUMAN; LETTER; NONHUMAN; OUTCOME ASSESSMENT; OVARIECTOMY; POSTMENOPAUSE;

EID: 34948820111     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31812e5258     Document Type: Letter

References (4)

1. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM. Isoflavone treatment for acute menopausal symptoms. Menopause 2007;14:468-473.
2. Conner P, Soderqvist G, Skoog L, et al. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. Breast Cancer Res Treat 2003;78:159-165.
3. Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 2006;13:831-839.
4. Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 2004;25:1649-1657